Showing 1 - 10 of 157
Grundlagen -- Gesamtwirtschaftliche Megatrends und die Aussicht auf dynamische Zukunftsindustrien in Japan -- Identifikation von Zukunftstechnologien in Japan -- Finanzierung von Zukunftstechnologien in Japan -- Mensch und Gesundheit -- Life Sciences und Biotechnologie in Japan -- Die japanische...
Persistent link: https://www.econbiz.de/10014014296
It's Not About the Technology is about a phenomenon most dreaded by high-technology industry executives: a failure at … notion that the success of execution lies neither in the technology nor in the market strategy. On the contrary, it is shaped …
Persistent link: https://www.econbiz.de/10014013944
volume offers an in-depth analysis of the Korean innovation system and shows how its science and technology policies actually …
Persistent link: https://www.econbiz.de/10013520825
theory approach it develops a model of how companies in technology intensive industries can improve the appropriation of the … equity develop along the technology-life-cycle and indicates how companies can, by an integrated technology and brand equity …
Persistent link: https://www.econbiz.de/10014014131
The worst chemical disaster ever could be happening right now. In India and Bangladesh between forty and eighty million people are at risk of consuming too much arsenic from well water that might have already caused one hundred thousand cancer cases and thousands of deaths. Many millions...
Persistent link: https://www.econbiz.de/10012054150
of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment … Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation …
Persistent link: https://www.econbiz.de/10012397599
Need for Optimal Design of Pharmaceutical Programs and Portfolios in Modern Medical Product Development -- Clinical Aspects of Pharmaceutical Portfolio Management -- Drug Development and the Cost of Capital -- Investment Considerations for Pharmaceutical Product Portfolios -- Challenges of...
Persistent link: https://www.econbiz.de/10014021346
Persistent link: https://www.econbiz.de/10013520463
This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...
Persistent link: https://www.econbiz.de/10013521260
Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...
Persistent link: https://www.econbiz.de/10013520588